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ABSTRACT
We previously reported that shokyo and kankyo, which are water-extracted fractions
of ginger, reduced LPS-induced PGE2 production in human gingival fibroblasts. In
this study, we examined the effects of these herbs on LPS-treated mouse macrophage
RAW264.7 cells. Both shokyo and kankyo reduced LPS-induced PGE2 production in a
concentration-dependent manner. Shokyo and kankyo did not inhibit cyclooxygenase
(COX) activity, nor did they alter the expression of molecules in the arachidonic acid
cascade. In addition, these herbs did not alter NF-κB p65 translocation into nucleus, or
phosphorylation of p65 or ERK. These results suggest that shokyo and kankyo inhibit
cPLA2 activity. Although 6-shogaol produced similar results to those of shokyo and
kankyo, the concentration of 6-shogaol required for the reduction of PGE2 production
were higher than those of 6-shogaol in shokyo and kankyo. Therefore, several gingerols
and shogaols other than 6-shogaol may play a role in the reduction of LPS-induced
PGE2 production. Thus, 6-shogaol, and other gingerols and shogaols inhibit cPLA2
activity and reduce LPS-induced PGE2 production via a different mechanism from
traditional anti-inflammatory drugs. Moreover, kampo medicines that contain shokyo
or kankyo are considered to be effective for inflammatory diseases.
Subjects Molecular Biology, Pharmacology
Keywords Kampo medicine, Kankyo, Herb, Shokyo, Arachidonic acid cascade, Antiinflammatory
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INTRODUCTION
Japanese traditional medicines (kampo medicines) are used for the treatment of several
inflammatory diseases. We focused on the inflammatory effects of these kampo medicines,
and found that lipopolysaccharide (LPS)-induced PGE2 production by human gingival
fibroblasts (HGFs) were reduced by several kampo medicines, including shosaikoto (TJ-
9) (Ara et al., 2008), orento (TJ-120) (Ara et al., 2010), hangeshashinto (TJ-14) (Nakazono
et al., 2010), kakkonto (TJ-1) (Kitamura, Urano & Ara, 2014), shinbuto (TJ-30), and
ninjinto (TJ-32) (Ara & Sogawa, 2017). Moreover, among the herbs contained in
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kakkonto, shokyo (Zingiberis Rhizoma), kanzo (Glycyrrhizae Radix), keihi (Cinnamomi
Cortex) (Ara & Sogawa, 2016), and kankyo (Zingiberis Processum Rhizoma) reduced PGE2
production (Ara & Sogawa, 2017). In particular, shokyo and kankyo strongly reduced
LPS-induced PGE2 production. These results suggested that kampo medicines that include
shokyo or kankyo have anti-inflammatory effects for periodontal disease.
Both shokyo and kankyo are contained in almost all kampo medicines, and are the
aqueous extracts of ginger (Zingiber offinale Roscoe). As described in the recent our
review (Ara et al., 2018), shokyo is the powdered rhizome of ginger, and kankyo is the
steamed and powdered rhizome of ginger. Many reports have demonstrated that ginger
possesses anti-inflammatory effects as below. Ginger is clinically used as a treatment for
rheumatoid arthritis, fever, emesis, nausea, andmigraine headache (Afzal et al., 2001), and a
systematic review revealed that the extracts of ginger are clinically effective as hypoanalgesic
agents (Lakhan, Ford & Tepper, 2015). In an animal model, orally- or intraperitoneal-
administrated aqueous extract of ginger reduced the serum PGE2 level in rats (Thomson et
al., 2002).Moreover, the crude hydroalcoholic extract of ginger reduced LPS-induced PGE2
serum level, and improved tracheal hyperreactivity and lung inflammation in rats (Aimbire
et al., 2007). Furthermore, ethanol extract of ginger reduced the tissue level of PGE2 and
improved acetic acid-induced ulcerative colitis in rats (El-Abhar, Hammad & Gawad,
2008).
In recent review (Alsherbiny et al., 2019), the effects of the aqueous extract of ginger are
summarized. For example, the aqueous extract of ginger reduced ultraviolet B-induced
inflammatory cytokines production in human keratinocyteHaCaT cells andmice (Guahk et
al., 2010) and LPS-induced inflammatory cytokines in mice (Choi et al., 2013). Moreover,
the aqueous extract of ginger has the protective effects against various organs such as
liver, kidney, neuron, and heart in mice and rats. However, there are few reports on
the effects on PGE2 production and the arachidonic acid cascade (Thomson et al., 2002;
Ara & Sogawa, 2016; Ara & Sogawa, 2017). Therefore, we examined the effects of shokyo
and kankyo themselves on PGE2 production and the arachidonic acid cascade in mouse
macrophageRAW264.7 cells.We also investigated the effects of 6-shogaol at a concentration
corresponding to that of these herbs.
MATERIALS AND METHODS
Reagents and cells
Powders of shokyo and kankyo were provided by Tsumura & Co. 3-D HPLC profiles of
shokyo and kankyo were shown in Fig. S1. These powders were suspended in Dulbecco’s
modified Eagle’s medium (D-MEM,Wako, Osaka, Japan) containing 10% heat-inactivated
fetal calf serum, 100 units/ml of penicillin, and 100 mg/ml of streptomycin (culture
medium), and were rotated at 4 ◦C overnight. Then, the suspensions were centrifuged and
the supernatants were filtered through a 0.45 µm pore membrane. Lipopolysaccharide
(LPS) from Porphyromonas gingivalis 381 was provided by Professor Nobuhiro Hanada
(School of Dental Medicine, Tsurumi University, Japan). Arachidonic acid and 6-shogaol
were purchased from Cayman Chemical (Ann Arbor, MI, USA). NF-κB inhibitor, BAY 11-
7082, was purchased fromWako. Mitogen-activated protein kinase kinase (MAPKK/MEK)
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inhibitor, PD98059, were purchased from Sigma (St. Louis, MO). Other reagents were
purchased from Nacalai Tesque.
The mouse macrophage cell line RAW264.7 (RIKEN BioResource Research Center,
Tsukuba, Japan) was cultured in culture medium at 37 ◦C in a humidified atmosphere of
5% CO2.
Measurement of cell viability
The numbers of viable cells were measured using WST-8 (Cell Counting Kit-8; Dojindo,
Kumamoto, Japan) according to the manufacturer’s instructions. In brief, cells were seeded
onto 96-well plates (AGC Techno Glass Co., Chiba, Japan) (50,000 cells/well), and treated
with shokyo or kankyo for 24 h. Then, the media were removed by aspiration and the cells
were treated with a 100 µl mixture of WST-8 with culture medium for 2 h at 37 ◦C in a
CO2 incubator.
The optical density was measured (measured wavelength at 450 nm and reference
wavelength at 655 nm) using an iMark microplate reader (Bio-Rad, Hercules, CA, USA),
and the mean background value was subtracted from each value. Data are presented as
mean ± SD (n= 4).
Measurement of prostaglandin E2 (PGE2)
RAW264.7 cells were seeded in 96-well plates (50,000 cells/well) and incubated in culture
medium at 37 ◦C overnight. For simultaneous treatment, cells were treated with varying
concentrations of each herb in the absence or presence of LPS (100 ng/ml) for 24 h (200 µl
per well) in triplicate or quadruplicate for each sample. For sequential treatment, cells were
treated with medium or LPS for 30 min, and thereafter treated with medium or each herb
for 24 h. After the culture supernatants were collected, viable cell numbers were measured
using WST-8 as described above.
The concentrations of PGE2 in the culture supernatantsweremeasured by enzyme-linked
immunosorbent assay (ELISA) according to the manufacturer’s instructions (Cayman
Chemical), and were adjusted by the number of viable cells. Data are presented as pg per
10,000 cells (mean ± SD).
Measurement of cytosolic phospholipase A2 (cPLA2) activity
cPLA2 activity was evaluated using cPLA2 Assay kit (Cayman Chemical) according to the
manufacturer’s instructions. RAW264.7 cells were cultured in 100-mm dishes, and treated
with 100 ng/ml of PgLPS for 2 h. Then, the cells were washed twice with Tris-buffered
saline (TBS), transferred into microcentrifuge tubes, and centrifuged at 6,000× g for 5
min at 4 ◦C. Supernatants were aspirated, and cells were resuspended in TBS with 1/100
volume of protease inhibitor cocktail (Nacalai tesque) and 1/100 volume of phosphatase
inhibitor cocktail (Nacalai tesque), and were homogenized with Dounce tissue grinder
(Sansyo, Tokyo, Japan), Then, cells were centrifuged at 12,000× g for 15 min at 4 ◦C. The
supernatant was collected and used as sample. To detect only cPLA2 activity, samples were
pretreated with 20 µM of bromoenol lactone [calcium-independent PLA2 (iPLA2)-specific
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inhibitor, Cayman Chemical] and 20 µM of thioetheramide-PC [secretory PLA2 (sPLA2)-
specific inhibitor, Cayman Chemical] for room temperature for 15 min. Bee venom PLA2
was used as positive control.
Measurement of cyclooxygenase (COX)-2 activity
COX-2 activity was indirectly evaluated as reported previously (Wilborn et al., 1995), with
slight modification. In brief, to estimate COX-2 activity, RAW264.7 cells (50,000 cells/well
in 96-well plate) were treated with LPS and each herb for 6 h (simultaneous treatment) or
LPS for 6 h and thereafter with each herb for 1 h (sequential treatment). Then, the cells
were washed and incubated in culture medium containing exogenous arachidonic acid (10
µM) for 30 min. The concentrations of PGE2 in the supernatants were measured by ELISA.
Data are presented as 100% at LPS alone (mean ± SD).
Preparation of cell lysates
RAW264.7 cells were cultured in 60-mm dishes, and treated with combinations of LPS
and herbs for the indicated times. Then, the cells were washed twice with TBS, transferred
into microcentrifuge tubes, and centrifuged at 6,000× g for 5 min at 4 ◦C. Supernatants
were aspirated and cells were lysed on ice in lysis buffer [50 mM Tris-HCl, pH 7.4, 1%
Nonidet P-40, 0.25% sodium deoxycholate, 150 mM NaCl, one mM ethyleneglycol bis(2-
aminoethylether)tetraacetic acid (EGTA), 1 mM sodium orthovanadate, 10 mM sodium
fluoride, 1/100 volume of protease inhibitor cocktail, and 1/100 volume of phosphatase
inhibitor cocktail] for 30 min at 4 ◦C. Samples were next centrifuged at 12,000× g for 15
min at 4 ◦C, and supernatants were collected. The protein concentration was measured
using a BCA Protein Assay Reagent kit (Pierce Chemical Co., Rockford, IL, USA).
Western blotting
The samples (50 µg of protein) were fractionated in a polyacrylamide gel under reducing
conditions and transferred onto a polyvinylidene difluoride (PVDF) membrane (Hybond-
P; GE Healthcare, Uppsala, Sweden). The membranes were blocked with 5% ovalbumin
for 1 h at room temperature and incubated with the primary antibody for an additional 1 h.
Themembranes were further incubated with horseradish peroxidase-conjugated secondary
antibodies for 1 h at room temperature. Protein bands were visualized with an ECL kit (GE
Healthcare). Protein levels were quantified using image analysis software ImageJ (National
Institutes of Health [NIH], Bethesda, MD).
Antibodies against COX-2 (sc-1745, 1:1,000 dilution), cPLA2 (sc-438, 1:500 dilution),
LOX-5 (LO-5, sc-515821, 1:250 dilution), annexin 1 (sc-11387, 1:1,000 dilution), actin
(sc-1616, 1:1,000 dilution), NF-κB p65 (sc-372, 1:1,000 dilution), and phosphorylated
p65 (Ser536) (p-NF-κB p65; sc-101752, 1:500 dilution) were purchased from Santa Cruz
Biotechnology (Santa Cruz, CA). Antibodies against extracellular signal-regulated kinase
(ERK; p44/42 MAP kinase antibody, 1:1,000 dilution) and phosphorylated ERK [Phospho-
p44/42 MAPK (Thr202/Tyr204) (E10) monoclonal antibody, 1:2,000 dilution] were from
Cell Signaling Technology (Danvers, MA). Horseradish peroxidase-conjugated anti-goat
IgG (sc-2020, 1:50,000 dilution) was from Santa Cruz, and anti-rabbit IgG (1:50,000
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dilution) and anti-mouse IgG (1:50,000 dilution) were from DakoCytomation (Glostrup,
Denmark).
Immunofluorescence staining
To detect p65 localization RAW264.7 cells were directly cultured on Lab-Tek chamber slides
(16 well, Thermo Fisher Scientific, Waltham, MA, USA) overnight. The cells were treated
with shokyo, kankyo (100 µg/ml), 6-shogaol (0, 0.1, 1, or 10 µM), or BAY 11-7082 (10 µM)
for 2 h, and further treated with LPS (100 ng/ml) and shokyo, kankyo, 6-shogaol, or BAY
11-7082 for 30 min. Then, the cells were fixed with ice-cold methanol for 30 min at−20 ◦C.
Subsequently, the cells were washed with PBS for 3 times, blocked with 1% BSA in PBS for
1 h, incubated with anti-p65 antibody (1:50 dilution) for 1 h at room temperature. After
washing with PBS for three times, cells were incubated for 1 h at room temperature with
Alexa Fluor488-conjugated secondary antibody (Thermo Fisher Scientific, 1:500 dilution).
After washing with PBS for three times, cells were mounted with VECTASHIELD Antifade
Mounting Medium with DAPI (Vector Laboratories, Burlingame, CA). Fluorescence was
visualized using Axioplan2 imaging (Carl Zeiss, Inc., Oberkochen, Deutschland).
Quantification of 6-shogaol in shokyo and kankyo
The quantification of 6-shogaol in each herb was performed by the Nagano Prefecture
Pharmaceutical Association Analytical Examination Center (Nagano, Japan). In brief,
one ml of samples (herbs in culture medium) was absorbed to a reverse-phase system
cartridge (SepPak tC18, Waters, Milford, MA, USA). Columns were washed with two ml
of 40% MeOH and one ml of 70% MeOH. Then, samples were eluted with 100% MeOH
and concentrated to one ml. These samples were subjected to high-performance liquid
chromatography (HPLC) with LC-20A (SHIMADZU, Kyoto, Japan). The conditions were
as follows: column, X-Bridge 2.1 × 150 mm, three µm (Waters); solvent, 70% aqueous
acetonitrile; flow rate, 0.15 min/ml; column oven, 40 ◦C; detection, 228 nm; and injection,
10 µl.
Statistical analysis
Differences between the control group and experimental groups were evaluated by a
two-tailed Dunnett’s test. All computations were performed with the statistical program
R (R Development Core Team, 2018). Dunnett’s test was performed using the ‘glht’ function
in the ‘multcomp’ package (Hothorn, Bretz & Westfall, 2008). The IC50 value and its 95%
confidence interval (CI) were calculated using the ‘drm’ function in the ‘drc’ package (Ritz
et al., 2015). Values with P < 0.05 were considered significantly different.
RESULTS
Effects of shokyo and kankyo on cell viability
We first examined the effects of shokyo and kankyo onRAW264.7 cell viability. Both shokyo
and kankyo reduced the cell viability in a concentration-dependent manner (Figs. 1A and
1B). However, the cell viability is hardly affected at 100 µg/ml of shokyo and kankyo, and
is slightly reduced at 1,000 µg/ml. Therefore, concentrations up to 100 µg/ml of shokyo
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Figure 1 Cytotoxicity of shokyo (A) and kankyo (B). RAW264.7 cells were treated with each herb (0,
100, 300, or 1,000 µg/ml) for 24 h. Then, the numbers of viable cells were measured by WST-8. P-values
vs. without each herb were calculated by Dunnett’s method. *P < 0.05, ***P < 0.001.
Full-size DOI: 10.7717/peerj.7725/fig-1
and kankyo were used in further experiments because we used the same concentration of
herbs in previous studies (Ara & Sogawa, 2016; Ara & Sogawa, 2017).
Effects of shokyo and kankyo on prostaglandin E2 (PGE2) production
Wenext examinedwhether shokyo and kankyo affect the production of PGE2 by RAW264.7
cells. The time schedule of treatment is shown in Fig. 2A. In the simultaneous treatment
experiment, RAW264.7 cells treated with 100 ng/ml of LPS produced PGE2. Shokyo and
kankyo (both 100 µg/ml) strongly reduced LPS-induced PGE2 production (Fig. 2B).
To exclude the possibility that components in these herbs non-specifically bind the LPS
receptor and inhibit LPS signaling, we performed a sequential treatment experiment. In this
experiment, the cells were treated with LPS first, and the LPS receptor was not inhibited.
The same results (Fig. 2C) as in the simultaneous treatment experiment were obtained,
suggesting that the reduction of PGE2 production is due to non-specific binding of the LPS
receptor by components in shokyo and kankyo. Therefore, we performed simultaneous
treatment in the following experiments.
We investigated the concentration-dependent effects of shokyo and kankyo on LPS-
induced PGE2 production. Both herbs reduced LPS-induced PGE2 production in a
concentration-dependent manner (Figs. 2D and 2E).
Effects of kankyo and shokyo on the arachidonic acid cascade
To clarify the mechanism by which shokyo and kankyo reduce LPS-induced PGE2
production more directly, we assessed the effects of these two herbs on the arachidonic
acid cascade. First, we examined cPLA2 activity using the homogenate of RAW264.7 cells.
However, we did not detect cPLA2 activity because the activity was background level (data
not shown). Next, we examined the effects of shokyo and kankyo on COX activity. In order
to bypass PLA2, we added exogenous arachidonic acid to RAW264.7 cells treated with
LPS alone or LPS plus herbs (simultaneous treatment experiment). Then, we measured
the PGE2 level produced by COX. Both shokyo and kankyo increased LPS-induced PGE2
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Figure 2 Effects of shokyo and kankyo on PGE2 production. (A) Time schedule of treatment with LPS
and/or each herb. Simultaneous treatment: Cells were treated with combinations of LPS (0 or 100 ng/ml)
and medium or each herb (100 µg/ml) for 24 h. Sequential treatment: Cells were treated with medium or
LPS (100 ng/ml) for 30 min, washed, and further treated with medium or each herb (100 µg/ml) for 24 h.
(continued on next page. . . )
Full-size DOI: 10.7717/peerj.7725/fig-2
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Figure 2 (. . .continued)
(B, C) Concentrations of PGE2 were measured by ELISA, adjusted by cell number, and expressed as 100%
at LPS alone (mean± SD, n = 3) in simultaneous (B) and sequential (C) treatment experiments. med,
medium; s, shokyo; k, kankyo. (D, E) Concentration-dependent effects of shokyo (D) and kankyo (E) on
LPS-induced PGE2 production. Cells were treated with combinations of LPS (100 ng/ml) and each herb
(0, 1, 10, or 100 µg/ml) for 24 h. P-values vs. with LPS alone were calculated by Dunnett’s method. *P <
0.05, **P < 0.01, ***P < 0.001.
production (Fig. 3B), suggesting that these two herbs increase COX-2 activity. Next,
to exclude the effects of the change in COX-2 expression, we performed the sequential
treatment experiment. As the cells were treated with LPS first in this experiment, COX-2
protein levels were considered to be comparable. Kankyo slightly increased COX-2 activity
(Fig. 3C). Based on these results, shokyo and kankyo do not inhibit COX-2 activity.
Next, we examined whether shokyo and kankyo affect the expression of molecules
in the arachidonic acid cascade. Shokyo and kankyo slightly reduced cPLA2 expression
(Fig. 3D). COX-2 was not expressed in the absence of LPS, and the treatment with LPS
alone increased COX-2 expression. Shokyo and kankyo did not alter LPS-induced COX-2
expression (Fig. 3D). Moreover, shokyo and kankyo did not alter annexin 1 expression
(Fig. 3D).
The expression of COX-2 is well known to be regulated by NF- κB. Therefore, we
analyzed NF-κB activation by the translocation of p65, a subunit of NF-κB, into nucleus.
p65 was localized at cytoplasm in untreated RAW264.7 cells. When RAW264.7 cells
were treated with LPS, p65 was mainly localized at nucleus although p65 was present in
cytoplasm (Fig. 4A). Shokyo and kankyo did not affect the p65 translocation into nucleus
(Fig. 4A). In addition, we analyzed NF-κB activation by the level of phosphorylation of
p65. Phosphorylated p65 (p-p65) was not detected without LPS treatment, and treatment
with LPS alone increased the p-p65 level. Pretreatment of shokyo or kankyo for 1 h did not
alter LPS-induced p65 phosphorylation (Fig. 4B), demonstrating that shokyo and kankyo
did not inhibit NF-κB activity.
Moreover, we evaluated the effects of shokyo and kankyo on ERK phosphorylation.
cPLA2 is directly phosphorylated and activated by phosphorylated ERK (Lin et al., 1993;
Gijón et al., 1999). Therefore, we examined whether shokyo and kankyo suppress LPS-
induced ERK phosphorylation. LPS treatment increased ERK phosphorylation at 0.5 h and
its phosphorylation was later attenuated. However, 100 µg/ml of shokyo or kankyo only
slightly reduced LPS-induced ERK phosphorylation (Fig. 4C).
We also evaluated the effects of shokyo and kankyo on the lipoxygenase pathway.
Lipoxygenase (LOX)-5 expression was not altered by LPS treatment. Moreover, LOX-5
expression was not affected by shokyo or kankyo (Fig. S2A). Shokyo and kankyo did not
change LOX activity because LTB4 production was not altered when arachidonic acid was
added (Figs. S2B and S2C). Furthermore, the LTB4 level was lower than that of PGE2
(Figs. 3B and 3C).
Quantification of 6-shogaol in shokyo and kankyo
6-Shogaol is one of the major and bioactive components in shokyo and kankyo. In order
to assess the effects of 6-shogaol on PGE2 production by RAW264.7 cells at a similar
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Figure 3 Effects of shokyo and kankyo on the arachidonic acid cascade. (A) Time schedule of treat-
ment with LPS and/or each herb. Simultaneous treatment: RAW264.7 cells were treated with LPS (100
ng/ml) and medium or each herb (100 µg/ml) for 6 h, washed, and then treated with 10 µM arachidonic
acid for 30 min. Sequential treatment: RAW264.7 cells were treated with LPS (100 ng/ml) for 6 h, and fur-
ther treated with medium or each herb (100 µg/ml) for 1 h. Then, the cells were washed and treated with
10 µM arachidonic acid for 30 min. (B, C) Effects of shokyo and kankyo on COX activity. (continued on
next page. . . )
Full-size DOI: 10.7717/peerj.7725/fig-3
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Figure 3 (. . .continued)
Concentrations of PGE2 were measured by ELISA, adjusted by cell number, and expressed as per 10,000
cells (mean± SD, n= 4) in simultaneous (B) and sequential (C) treatment experiments. P-values vs. with
LPS alone by Dunnett’s test are indicated. (D) Effects of herbs on cPLA2, annexin 1, and COX-2 expres-
sion. RAW264.7 cells were treated with a combination of LPS (0 or 100 ng/ml) and medium, each herb
(100 µg/ml), or dexamethasone (100 nM) for 8 h, and protein levels were examined by Western blotting.
med, medium; s, shokyo; k, kankyo; and Dex, dexamethasone. The band densities were normalized against
LPS alone and actin. The values were indicated below each band.
Figure 4 Effects of shokyo and kankyo on the intracellular signal transduction. (A) Effects of herbs on
NF-κB p65 translocation into nucleus. RAW264.7 cells were treated with each herb (100 µg/ml), or BAY
11-7082 (10 µM) for 2 h, and further treated with LPS (100 ng/ml), and 6-shogaol or BAY 11-7082 for 30
min. The cellular localization of p65 was determined by immunofluorescence analysis. Nuclei of the cor-
responding cells were visualized with DAPI, and observed at 400×magnification. The bar represents 20
µm. (B, C) Effects of herbs on NF-κB p65 and ERK phosphorylation. RAW264.7 cells were treated with
each herb (100 µg/ml), BAY 11-7082 (10 µM), or PD98059 (20 µM) for 1 h, and further treated with LPS
(100 ng/ml) and each herb, BAY 11-7082, or PD98059 for 15 min. p65 and phosphorylated p65 levels (B),
and ERK and phosphorylated ERK (pERK) levels (C) were examined by Western blotting. The upper band
indicates ERK1 (p44 MAPK) and the lower band indicates ERK2 (p42 MAPK) in (C). med, medium; s,
shokyo; k, kankyo; BAY, BAY 11-7082, and PD, PD98059. The band densities were normalized against
LPS alone, and p65 or ERK. The values were indicated below each band.
Full-size DOI: 10.7717/peerj.7725/fig-4
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Table 1 Concentrations of 6-shogaol in shokyo and kankyo by HPLC analysis.
Concentration of herb
5 mg/ml 100µg/ml
shokyo 2.97 µM 59.4 nM
kankyo 4.87 µM 97.4 nM
Notes.
Chromatography profiles are shown in Fig. S3.
concentration to shokyo and kankyo, we quantified the amount of 6-shogaol in shokyo
and kankyo. HPLC analysis revealed that the 5 mg/ml shokyo and kankyo solutions used
in this study contained 2.97 µM and 4.87 µM 6-shogaol, respectively (Table 1 and Fig. S3).
Thus, 100 µg/ml of shokyo and kankyo contained 59.4 nM and 97.4 nM 6-shogaol,
respectively (Table 1).
Effects of 6-shogaol on PGE2 production and molecular expression
in the arachidonic acid cascade
We investigated the effects of 6-shogaol on LPS-induced PGE2 production by RAW264.7
cells. 6-Shogaol reduced LPS-induced PGE2 production in a concentration-dependent
manner (Fig. 4A). One hundred nM 6-shogaol reduced PGE2 production to approximately
50%, and 1,000 nM (= 1 µM) 6-shogaol inhibited PGE2 production. The IC50 value of
6-shogaol was 105 nM (95% CI: 27.7–182 nM). However, comparing with the calculated
6-shogaol concentration in shokyo and kankyo based on the results in Table 1, the effects
of 6-shogaol on PGE2 production were weaker than those of shokyo and kankyo (red and
blue lines in Fig. 5A, respectively).
The effects of 6-shogaol on the expression of molecules in the arachidonic acid cascade
and intracellular signal transduction pathways were evaluated, but 10 µM 6-shogaol did
not affect the expression of cPLA2, annexin 1, or COX-2 (Fig. 5B). Moreover, 6-shogaol did
not affect LPS-induced p65 translocation into nucleus (Fig. 6A), or p65 phosphorylation
(Fig. 6B). Furthermore, 6-shogaol did not alter ERK phosphorylation (Fig. 6C).
DISCUSSION
There are few reports on the effects of shokyo or kankyo, which are aqueous extracts of
ginger, on the arachidonic acid cascade. We previously examined the effects of shokyo
and kankyo on the arachidonic acid cascade in HGFs, and suggested that these herbs
inhibit cPLA2 activity because they did not inhibit COX-2 activity or suppress cPLA2 and
COX-2 expression (Ara & Sogawa, 2016; Ara & Sogawa, 2017). In this study, we examined
the effects of these herbs in macrophage-like RAW264.7 cells and obtained similar results
(Figs. 3B–3D). In addition, shokyo and kankyo did not alter annexin 1 (also named
lipocortin1) expression (Fig. 3D), which is produced by glucocorticoids and inhibits cPLA2
activity (Gupta et al., 1984; Wallner et al., 1986). Moreover, shokyo and kankyo did not
alter NF-κB p65 translocation into nucleus (Fig. 4A), p65 phosphorylation (Fig. 4B), or
ERK phosphorylation (Fig. 4C). Because NF-κB activation is required to induce COX-2
expression, our results that shokyo and kankyo did not alter COX-2 expression (Fig. 3D)
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Figure 5 Effects of 6-shogaol on LPS-induced PGE2 production, and the arachidonic acid cascade.
(A) Effects of 6-shogaol on LPS-induced PGE2. RAW264.7 cells were treated with LPS (100 ng/ml) and 6-
shogaol (0 to 1,000 nM) for 24 h. Concentrations of PGE2 were measured by ELISA, adjusted by cell num-
ber, and expressed as per 10,000 cells (mean± SD, n= 3). P-values vs. with LPS alone were calculated by
Dunnett’s method. *P < 0.05, **P < 0.01, ***P < 0.001. Red and blue lines represent the effects of shokyo
and kankyo in Figs. 2D and 2E, respectively. The concentrations of 6-shogaol in shokyo and kankyo were
calculated using the results shown in Table 1. (B) Effects of 6-shogaol on cPLA2, annexin 1, and COX-2
expression. RAW264.7 cells were treated with a combination of LPS (0 or 100 ng/ml) and 6-shogaol (0,
0.1, 1, or 10 µM), or dexamethasone (100 nM) for 8 h, and protein levels were examined by Western blot-
ting. The band densities were normalized against LPS alone and actin. The values were indicated below
each band.
Full-size DOI: 10.7717/peerj.7725/fig-5
are consistent with those in NF-κB activation. In addition, because ERK phosphorylation is
required to activate cPLA2, our results suggest that shokyo and kankyo did not alter cPLA2
activation. Unfortunately, we could not directly evaluate the effects of shokyo, kankyo, and
6-shogaol on cPLA2 activity in this study, because cPLA2 activity of RAW264.7 cells were
not detected. However, these results suggest that shokyo and kankyo inhibit cPLA2 activity
in RAW264.7 cells and in HGFs, and their effects may be cell type-nonspecific.
As a possible mechanism by which shokyo and kankyo reduced LPS-induced PGE2
production, components of shokyo and kankyo may bind to LPS receptors on the cell
surface and inhibit LPS signaling. However, even after the removal of LPS, shokyo and
kankyo reduced LPS-induced PGE2 production in the sequential treatment experiment
(Fig. 2C). If some components in these herbs either competitively or noncompetitively
block LPS receptors or reduce PGE2 production, LPS-induced NF-κB p65 and ERK
phosphorylation should have been inhibited. However, shokyo and kankyo did not
suppress LPS-induced NF-κB and ERK phosphorylation (Figs. 4B and 4C). These results
therefore excluded this hypothesis, and the target sites of shokyo and kankyo are present
intracellularly.
Gingerols and shogaols are the major components of ginger (reviewed in Ara et al.,
2018); therefore, shokyo and kankyo contain these components. With prolonged storage
or heating of ginger, gingerols are dehydrated and converted to shogaols (Afzal et al.,
2001). Because kankyo is subjected to heat processing, kankyo contains a larger amount of
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Figure 6 Effects of 6-shogaol on the intracellular signal transduction. (A) Effects of 6-shogaol on NF-
κB p65 translocation into nucleus. RAW264.7 cells were treated with 6-shogaol (0, 0.1, 1, or 10 µM), or
BAY 11-7082 (10 µM) for 2 h, and further treated with LPS (100 ng/ml), and 6-shogaol or BAY 11-7082
for 30 min. The cellular localization of p65 was determined by immunofluorescence analysis. Nuclei of the
corresponding cells were visualized with DAPI, and observed at 400×magnification. The bar represents
20 µm. (B, C) Effects of 6-shogaol on NF-κB p65 and ERK phosphorylation. RAW264.7 cells were treated
with 6-shogaol (0, 0.1, 1, or 10 µM), BAY 11-7082 (10 µM), or PD98059 (20 µM) for 1 h and further
treated with LPS (100 ng/ml), and 6-shogaol, BAY 11-7082, or PD98059 for 15 min. p65 and phosphory-
lated p65 levels (B), and ERK and phosphorylated ERK (pERK) levels (C) were examined by Western blot-
ting. BAY: BAY 11-7082, and PD: PD98059. The band densities were normalized against LPS alone, and
p65 or ERK. The values were indicated below each band.
Full-size DOI: 10.7717/peerj.7725/fig-6
shogaols than shokyo as shown in Fig. S1. Among them, 6-shogaol is one of the bioactive
components, and was reported to reduce PGE2 production (Ara et al., 2018). Indeed,
kankyo contained 1.7-times the amount of 6-shogaol as shokyo (approximately 60 nM and
100 nM 6-shogaol in 100 µg/ml of shokyo and kankyo, respectively). However, because
shokyo and kankyo are water-extracts of ginger, the amount and effects of gingerols and
shogaols are thought to be lower than those of organic solvent-extracts such as methanol.
Next, we will discuss the effects of 6-shogaol on PGE2 production. In this study, the IC50
value of 6-shogaol for PGE2 production was approximately 100 nM (Fig. 5A). This IC50
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value is consistent with that in previous reports: approximately 100 nM in IL-1β-treated
human oral keratinocytes (Kono et al., 2014) and approximately 60 µg/ml (= 217 nM)
in LPS-treated U937 cells (Lantz et al., 2007). However, the IC50 value in this study was
considered to be insufficient to inhibit the arachidonic acid cascade, as described below.
The IC50 value of 6-shogaol for COX-2 activity is 2.1 µM in A549 cells (Tjendraputra
et al., 2001). In another report, 6-shogaol did not inhibit COX-activity in a cell-free
experimental model (Van Breemen, Tao & Li, 2011). Although we did not examine the
effects of 6-shogaol on COX-2 activity, 100 nM 6-shogaol was considered to not affect
COX-2 activity because 100 µg/ml of kankyo, which contains approximately 100 nM
6-shogaol, did not inhibit COX-2 activity. Moreover, 0.17 µM 6-shogaol reduced COX-2
activity to approximately 70% in IL-1β-treated human oral keratinocytes (Kono et al.,
2014). The reported concentrations of 6-shogaol required for the reduction of COX-2
expression were higher than that in our study. The expression of COX-2 mRNA was
reduced to approximately 70% by 0.17 µM 6-shogaol (Kono et al., 2014). However, the
expression of COX-2 protein was not affected by 1 µM 6-shogaol, was slightly reduced
by 5 µM, and was significantly reduced by 10 µM in LPS-treated mouse microglial BV-2
cells (Ha et al., 2012). Therefore, our results that shokyo and kankyo did not inhibit
COX activity are consistent with these previous reports. Similar results were observed in
mouse skin (Kim et al., 2005). Similarly, a high concentration of 6-shogaol was reported
to be required for the inhibition of NF-κB activation. PMA-induced NF-κB promoter
activity was reduced to approximately 50%, but p65 phosphorylation was not affected by
5 µM shogaol in human breast carcinoma cells (Ling et al., 2010). In this study, even 10
µM 6-shogaol did not affect cPLA2 or COX-2 expression, p65 translocation to nucleus
(Fig. 6A), or p65 phosphorylation (Fig. 6B) Therefore, our results are consistent with
these previous results. Our results suggested that 6-shogaol reduces LPS-induced PGE2
production via the inhibition of cPLA2 activity because the remaining and probable target
site in the arachidonic acid cascade is cPLA2.
However, the effects of shokyo and kankyo cannot be accounted for by only 6-
shogaol. Although 100 µg/ml of kankyo reduced LPS-induced PGE2 production to
approximately 10% (Fig. 2E), 100 nM 6-shogaol reduced it to approximately 50% (Fig. 5A).
Therefore, some components other than 6-shogaol may be involved in the reduction of
PGE2 production. It was previously reported that 6-gingerol is the most abundant in
hangeshashinto, which contains kankyo (Kono et al., 2014). Moreover, the amount of
6-shogaol is approximately half of that of 6-gingerol, and the amounts of 8-gingerol,
10-gingerol, 8-shogaol, and 10-shogaol are smaller (Kono et al., 2014). 6-Shogaol reduced
PGE2 production themost, followed by 6-gingerol, 8- and 10-gingerol, and slight reduction
by 8- and 10-shogaol (Kono et al., 2014). Thus, the effects of 6-shogaol on the reduction
of PGE2 production are the strongest and those of other components are weak. Therefore,
gingerols and shogaols may have additive effects on PGE2 production. Next, we will discuss
the effects of gingerols and shogaols on the arachidonic acid cascade. The IC50 values of
these components for the inhibition of COX-2 activity are on the order of µM, similar
to 6-shogaol (Tjendraputra et al., 2001; Van Breemen, Tao & Li, 2011). Moreover, 6-, 8-,
and 10-gingerol reduced COX-2 expression at the µM order (Lantz et al., 2007). Among
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ginger extracts, 10 µM 10-gingerol, 6-shogaol, 8-shogaol, and 10-shogaol reduced cPLA2
activity to approximately 50% (Nievergelt et al., 2011). Although the concentrations of
these components in shokyo and kankyo are lower than 10 µM, shokyo and kankyo may
inhibit cPLA2 activity by their additive effects.
We next evaluated the effects of shokyo and kankyo on the LOX pathway. However,
RAW264.7 cells produced only a small amount of LTB4 regardless of the presence of LPS.
Moreover, shokyo and kankyo did not affect LOX-5 expression or LOX activity, suggesting
that the LOX pathway is not active in macrophages, and that shokyo and kankyo do not
inhibit the lipoxygenase pathway. Aspirin-induced asthma (AIA) is induced by the ingestion
of acid nonsteroidal anti-inflammatory drugs (NSAIDs), and is considered to be caused
by leukotrienes, which are increased by acid NSAIDs an contract the bronchus (Vaszar &
Stevenson, 2001; Bochenek et al., 2002). Similarly, acid NSAIDs exacerbate general asthma.
Based on our findings that (1) shokyo and kankyo inhibit upstream of the arachidonic
acid cascade, (2) they did not inhibit the cyclooxygenase pathway, and (3) they did not
enhance lipoxygenase pathways, shokyo and kankyo may reduce leukotriene production.
Therefore, shokyo and kankyo may not exacerbate asthma, including AIA. As such,
shokyo and kankyo may be safely used for patients with asthma, including AIA, instead of
conventional anti-inflammatory drugs. Moreover, as oral-administrated ginger protected
aspirin-induced gastric ulcers in rats (Wang et al., 2011), shokyo and kankyo may be
available as anti-inflammatory drugs instead of NSAIDs.
Next, we will discuss about protective effect on gastric ulcer. In general, ginger reduced
PGE2 production in macrophages and inflammatory site. In contrast, orally administered
cuttlebone complex (CBC), which includes fresh ginger roots, demonstrated a protective
potentiality against indomethacin-induced gastric ulcer in rats via increment of the
indomethacin-declined PGE2 levels in the stomach (Chien et al., 2015). Therefore, ginger
has opposite effects between inflammatory cells and gastric mucosal cells. Moreover, ginger
powder protected aspirin-induced gastric ulcers in rat (Wang et al., 2011). These results
suggest that ginger has both anti-inflammatory effect and protective effect on gastric ulcers
in contrast to acid NSAIDs.
There are several limitations in this study. We evaluated only cPLA2 among PLA2
isotypes. Therefore, in the future, the evaluation of the effects of shokyo and kankyo on
iPLA2 and sPLA2—expressions and activities—will be needed. Moreover, the evaluation
of the anti-inflammatory effects of shokyo and kankyo on the inflammatory diseases such
as periodontal disease or stomatitis by animal models will be needed.
CONCLUSION
We demonstrated that shokyo and kankyo, which are water-extracted fractions of ginger,
reduced LPS-induced PGE2 production in RAW264.7 cells. Their mechanisms of action
were suggested to via the inhibition of cPLA2 activity because both herbs did not inhibit
COX activity or suppress the expression of molecules in the arachidonic acid cascade.
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